Cat. #155088
Anti-FVIII [MBC 301.3]
Cat. #: 155088
Unit size: 100 ug
Availability: 10-12 weeks
Target: Factor VIII
Class: Monoclonal
Application: ELISA
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Versiti Blood Research Institute
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-FVIII [MBC 301.3]
- Alternate name: FVIII
- Research fields: Immunology
- Class: Monoclonal
- Conjugation: Unconjugated
- Host: Mouse
- Application: ELISA
- Description: Factor VIII is an essential blood-clotting protein encoded by the F8 gene in humans. This protein circulates in the blood stream in an inactive form, bound to vWF, until an injury that damages blood vessels occurs.
- Immunogen: Recom hu. FVIII
- Myeloma used: P3X63Ag8.653
- Recommended controls: IgG1
Target Details
- Target: Factor VIII
- Target background: Factor VIII is an essential blood-clotting protein encoded by the F8 gene in humans. This protein circulates in the blood stream in an inactive form, bound to vWF, until an injury that damages blood vessels occurs.
Applications
- Application: ELISA
Handling
- Format: Liquid
- Concentration: 0.9-1.1mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Lacroix-Desmazes et al. 2016. Blood. 128(16):1999-2001. PMID: 28157675.
- Meeks et al. 2012. Blood. 120(12):2512-20. PMID: 22855607.
- Irigoyen et al. 2011. Haemophilia. 17(2):267-74. PMID: 21070488.
- Powell et al. 2009. Ther Clin Risk Manag. 5(2):391-402. PMID: 19536318.
- Yarovoi et al. 2003. Blood. 102(12):4006-13. PMID: 12881300.
